Latest Breaking News On - Merck exclusive license - Page 1 : comparemela.com

Kineta Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Kineta Reports Third Quarter 2023 Financial Results and Provides Corporate Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Shawn iadonatoJacques bouchyJohn mullalySociety for immunotherapy of cancerResearch collaboration agreementKineta incFred hutchinson cancer centerSlab programLifesci advisorsInvestor relations business developmentReports third quarterProvides corporateCash runwayChief executive officerGuillaudeux phdChief scientific officer

Kineta Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Kineta Reports Second Quarter 2023 Financial Results and Provides Corporate Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesScott dyllaRobert burnsJacques bouchyShawn iadonatoKim drapkinJohn vandermostenJohn mullalyResearch collaboration agreementHc wainwright coMillion researchDevelopment collaboration milestone paymentInvestor relations business developmentLifesci advisorsZack investment researchKineta inc

Kineta Reports Second Quarter 2023 Financial Results and Provides Corporate Update

11.08.2023 - Initial Clinical Data Readout from Ongoing Phase 1/2 Study of VISTA-Targeting KVA12123 in Advanced Solid Tumors Anticipated by End of 2023 Received $5 Million Research and Development Collaboration Milestone Payment from Merck Cash Runway into .

United statesShawn iadonatoRobert burnsJohn mullalyJohn vandermostenKim drapkinJacques bouchyScott dyllaResearch collaboration agreementHc wainwright coZack investment researchInvestor relations business developmentKineta incLifesci advisorsCash runwayChief executive officer